Recent advances in exacerbations of asthma

Thorax

Volumn 63, Issue 9, 2008, Pages 758-760

  Sykes, Annemarie ^a   Seemungal, Terence ^b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b UNIVERSITY OF THE WEST INDIES   (Trinidad and Tobago)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; BECLOMETASONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA INTERFERON; BUDESONIDE PLUS FORMOTEROL; CORTICOSTEROID; ERYTHROMYCIN; FLUTICASONE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E ANTIBODY; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; KETOLIDE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MACROLIDE; MONTELUKAST; NITRIC OXIDE; SALBUTAMOL; SALMETEROL; TELITHROMYCIN; TOBACCO SMOKE; TUMOR NECROSIS FACTOR ALPHA; ZAFIRLUKAST;

ALLERGIC ASTHMA; ASTHMA; BRONCHOSPASM; CHLAMYDOPHILA PNEUMONIAE; DISEASE EXACERBATION; DISEASE SEVERITY; EDITORIAL; EOSINOPHIL; EXPIRATORY FLOW; EXPOSURE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; LUNG FUNCTION; MORBIDITY; MORTALITY; PATHOGENESIS; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RHINOVIRUS; SPUTUM; SYMPTOM; VACCINATION; VIRAL RESPIRATORY TRACT INFECTION; VIRUS INFECTION; VIRUS LOAD;

EID: 51249101312     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2008.099036     Document Type: Editorial

References (29)

1. Corne JM, Marshall C, Smith S, et al. Freguency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet 2002;359:831-4.
2. Green RM, Custovic A, Sanderson G, et al. Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study BMJ 2002;324:763.
3. Murray CS, Poletti G. Kebadze T, et al. Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children. Thorax 2006;61:376-82.
4. Wark PAB, Johnston SL, Bucchieri F, et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 2005;201:937-47.
5. Contoli M, Message SD, Laza-Stanca V, et al. Role of deficient type III interferon-[lambda] production in asthma exacerbations. Nat Med 2006;12:1023-6.
6. Bartlett NW, Walton RP, Edwards MR, et al. Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation. Nat Med 2008;14:199-204.
7. BouletL-P, Gauvreau G, Boulay M-E, et al. The allergen bronchoprovocation model: an important tool for the investigation of new asthma anti-inflammatory therapies. Allergy 2007;62:1101-10.
8. Cunningham AF, Johnston SL, Julious SA, et al Chronic Chlamydia pneumoniae infection and asthma exacerbations in children. Eur Respir J 1998;11:345-9.
9. Wark PAB, Johnston SL, Simpson JL, et al. Chlamydia pneumoniae immunoglobulin A reactivation and airway inflammation in acute asthma. Eur Respir J 2002;20:834-40.
10. Johnston SL, Blasi F, Black PN, et al. The effect of telithromycin in acute exacerbations of asthma. N Engl J Med 2006;354:1589-600.
11. Johnston NW, Johnston SL, Duncan JM, et al. The September epidemic of asthma exacerbations in children: A search for etiology. J Allergy Clin Immunol 2005;115:132-8.
12. Boudreaux ED, Emond SD, Clark S, et al. Acute asthma among adults presenting to the emergency department: the role of race/ethnicity and socioeconomic status. Chest 2003;124:803-12.
13. Jones SL, Kittelson J, Cowan JO, et al. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med 2001;164:738-43.
14. Frey U, Brodbeck T, Majumdar A, et al. Risk of severe asthma episodes predicted from fluctuation analysis of airway function. Nature 2005;438:667-70.
15. Hacking D, Knight JC, Rockett K, et al. Increased in vivo transcription of an IL-8 haplotype associated with respiratory syncytial virus disease-susceptibility. Genes Immun 2004;5:274-82.
16. Lougheed MD, Fisher T, D'Donnell DE. Dynamic hyperinflation during bronchoconstriction in asthma: implications for symptom perception. Chest 2006;130:1072-81.
17. Jayaram L, Pizzichini MM, Cook RJ, et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J 2006;27:483-94.
18. Pizzichini M, Pizzichini E, Eftthimiadis A, et al. Asthma and natural colds. Inflammatory indices in induced sputum: a feasibility study. Am J Respir Crit Care Med 1998;158:1178-84.
19. Smith AD, Cowan JO, Brassett KP, et al. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005;352:2163-73.
20. Pauwels RA, Lofdahl CG, Postma D, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 1997;337:1405-11.
21. Pauwels RA, Pedersen S, Busse WW, START Investigators Group. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet 2003;361:1071-6.
22. Sorkness CA, Lemanske RF, Mauger D, et al. Long term comparison of 3 controller regimes for mild-moderate persistent childhood asthma: The paediatric asthma controller trial. J Allergy Clin Immunol 2007;119:64-72.
23. Barnes NC, Miller CJ. Effect of leukotriene receptor antagonist therapy on the risk of asthma exacerbations in patients with mild to moderate asthma: an integrated analysis of zafirlukast trials. Thorax 2000;55:478-83.
24. Johnston NW, Mandhane PJ, Dai J, et al. Attenuation of the September epidemic of asthma exacerbations in children: a randomized, controlled trial of montelukast added to usual therapy. Pediatrics 2007;120:e702-12.
25. Rees PJ. Omalizumab reduces exacerbation and steroid use in chronic asthma. Arch Dis Child Ed Pract 2007;92:ep127.
26. O'Byrne PM, Bisgaard H, Godard PP, et al. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med 2005;171:129-36.
27. Rabe KF, Atienza T, Magyar P, et al. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Lancet 368:744-53.
28. Papi A, Canonica GW, Maestrelli P, et al. Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. N Engl J Med 2007;356:2040-52.
29. Rabe KF, Vermeire PA, Soriano JB, et al. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000;16:802-7.